135 related articles for article (PubMed ID: 38841851)
41. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
Dis Esophagus; 2007; 20(1):36-41. PubMed ID: 17227308
[TBL] [Abstract][Full Text] [Related]
42. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
43. Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas.
Ferrer-Torres D; Nancarrow DJ; Kuick R; Thomas DG; Nadal E; Lin J; Chang AC; Reddy RM; Orringer MB; Taylor JM; Wang TD; Beer DG
Oncotarget; 2016 Aug; 7(34):54867-54882. PubMed ID: 27363029
[TBL] [Abstract][Full Text] [Related]
44. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer.
Pyo JH; Lee H; Min YW; Min BH; Lee JH; Kim KM; Yoo H; Ahn S; Kim JJ
Gastric Cancer; 2018 Jul; 21(4):672-679. PubMed ID: 29243195
[TBL] [Abstract][Full Text] [Related]
45. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
46. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
Front Oncol; 2021; 11():748694. PubMed ID: 34926257
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
48. Transhiatal distal esophagectomy for Siewert type II cardia cancer can be a treatment option in selected patients.
Reddavid R; Strignano P; Sofia S; Evangelista A; Deiro G; Cannata G; Chiaro P; Maiello F; Mineccia M; Ferrero A; Leli R; Gentilli S; Polastri R; Borghi F; Camandona M; Romagnoli R; Morino M; Degiuli M
Eur J Surg Oncol; 2019 Oct; 45(10):1943-1949. PubMed ID: 31005469
[TBL] [Abstract][Full Text] [Related]
49. Surgical Treatment of Gastroesophageal Junction Cancer.
Hashimoto T; Kurokawa Y; Mori M; Doki Y
J Gastric Cancer; 2018 Sep; 18(3):209-217. PubMed ID: 30275998
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography?
Pedrazzani C; Bernini M; Giacopuzzi S; Pugliese R; Catalano F; Festini M; Rodella L; de Manzoni G
J Surg Oncol; 2005 Sep; 91(4):226-31. PubMed ID: 16121346
[TBL] [Abstract][Full Text] [Related]
51. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
[TBL] [Abstract][Full Text] [Related]
52. Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution retrospective cohort study.
Zhang W; Chen X; Liu K; Yang K; Chen X; Zhao Y; Zhao Y; Chen J; Chen L; Hu J
Chin J Cancer Res; 2016 Aug; 28(4):413-22. PubMed ID: 27647969
[TBL] [Abstract][Full Text] [Related]
53. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
Jin P; Ma G; Liu Y; Ke B; Liu HM; Liang H; Zhang RP
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):54-62. PubMed ID: 38262901
[No Abstract] [Full Text] [Related]
54. Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements.
Roedl JB; Prabhakar HB; Mueller PR; Colen RR; Blake MA
Acad Radiol; 2009 Feb; 16(2):218-26. PubMed ID: 19124108
[TBL] [Abstract][Full Text] [Related]
55. The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy.
Feng F; Tian Y; Xu G; Liu S; Liu Z; Zheng G; Guo M; Lian X; Fan D; Zhang H
Springerplus; 2016; 5():588. PubMed ID: 27247885
[TBL] [Abstract][Full Text] [Related]
56. Clinical and Therapeutic Implications of the 8th Edition TNM Classification of Adenocarcinomas of the Esophagogastric Junction.
Birla R; Gandea C; Hoara P; Caragui A; Marica C; Vasiliu E; Constantinoiu S
Chirurgia (Bucur); 2018; 113(6):747-757. PubMed ID: 30596362
[TBL] [Abstract][Full Text] [Related]
57. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
[TBL] [Abstract][Full Text] [Related]
58. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction.
Marsman WA; Tytgat GN; ten Kate FJ; van Lanschot JJ
J Surg Oncol; 2005 Dec; 92(3):160-8. PubMed ID: 16299781
[TBL] [Abstract][Full Text] [Related]
59. Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus.
Altorjay A; Paal B; Sohar N; Kiss J; Szanto I; Sohar I
World J Gastroenterol; 2005 Oct; 11(37):5751-6. PubMed ID: 16270380
[TBL] [Abstract][Full Text] [Related]
60. HER2 expression in carcinomas of the true cardia (Siewert type II esophagogastric junction carcinoma).
Katai H; Ishida M; Yamashita H; Ohashi M; Morita S; Katayama H; Fukagawa T; Kushima R
World J Surg; 2014 Feb; 38(2):426-30. PubMed ID: 24114368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
